Manufacture of perfume and toilet preparations
PHARMALAB AS
Revenue 2025
NOK 1.8m
Operating profit
NOK −297,000
Equity
NOK 923,000
Incorporated
1995
Share capital
NOK 100,000
Key figures · 2025
Current ratio
2.69
Equity ratio
64.5%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -16.4% | |
| Net margin (%%) | -16.6% | |
| Return on assets (%%) | -20.7% | |
| Likviditet | ||
| Current ratio | 2.69 | |
| Working capital | 861k | |
| Soliditet | ||
| Equity ratio (%%) | 64.5% | |
| Debt-to-equity ratio | 0.55 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.